Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa

Lenacapavir rollout in South Africa: A groundbreaking step in HIV prevention

South Africa's launch of Lenacapavir marks a transformative moment in the fight against HIV, promising to significantly reduce new infections and improve health outcomes for millions.